Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,837,566
in 4 filings, $626K under 10b5-1 plans

Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 78 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-05-16 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −15,900 63,700
2016-04-15 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +15,900 $0.98 $16K 179,497
2016-04-15 Kelbon Marcia S. VP Patent and General Counsel Sale −15,900 $15.18 $241K 163,597
2016-04-15 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −15,900 79,600
2016-03-24 Cable Thomas J. Director Sale −1,600 $14.71 $24K 49,467
2016-03-24 Cable Thomas J. Director Sale −400 $15.22 $6K 49,067
2016-03-23 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +15,171 $4.10 $62K 163,597
2016-03-23 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −15,171 87,529
2016-03-15 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +15,900 $0.98 $16K 164,326
2016-03-15 Kelbon Marcia S. VP Patent and General Counsel Sale −15,900 $15.12 $240K 148,426
2016-03-15 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) +15,900 95,500
2016-03-08 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +31,800 $0.98 $31K 180,226
2016-03-08 Kelbon Marcia S. VP Patent and General Counsel Sale −31,800 $15.03 $478K 148,426
2016-03-08 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −31,800 111,400
2016-02-19 Demopulos Gregory A MD Chairman, CEO & President Grant or award · Stock Option (Right to Buy) +400,000 400,000
2016-02-19 JACOBSEN MICHAEL A VP Finance and CAO Grant or award · Stock Option (Right to Buy) +85,000 85,000
2016-02-19 Kelbon Marcia S. VP Patent and General Counsel Grant or award · Stock Option (Right to Buy) +80,000 80,000
2016-01-14 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +10,000 $4.10 $41K 148,426
2016-01-14 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −10,000 102,700
2016-01-14 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +100,000 $0.98 $98K 1,703,822

Page 18 of 20 · 391 trades